NICE backs Lynparza across the board for BRCA+ovarian cancer

FDA grants AZ's Imfinzi fast review in new lung cancer use

The FDA has granted AstraZeneca’s Imfinzi immunotherapy a faster six-month review in patients with extensive-stage small cell lung cancer.

AZ and Novoheart collaborate on 'heart in a jar', to develop...

Stem cell biotech Novoheart is to collaborate with AstraZeneca to develop a “heart in a jar” that will be used to help develop new heart failure drugs.

FDA nod for AZ’s Calquence sets up new Imbruvica showdown

AstraZeneca, Merck cue up FDA verdict on selumetinib next ye...

AZ fleshes out positive trial of revitalised lupus drug anif...